Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

What did PROVE-IT prove?

William L Isley1,

  • 1Mayo College of Medicine Division of Endocrinology, Nutrition, and Metabolism, Mayo Clinic, Rochester, Minnesota 55905, USA. isley.william@mayo.edu

Diabetes Technology & Therapeutics
|February 3, 2005
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thyroid dysfunction in the severely ill and elderly.

Postgraduate medicine·2017
Same author

Pilot study of combined therapy with ω-3 fatty acids and niacin in atherogenic dyslipidemia.

Journal of clinical lipidology·2011
Same author

LDLR promoter variant and exon 14 mutation on the same chromosome are associated with an unusually severe FH phenotype and treatment resistance.

European journal of human genetics : EJHG·2008
Same author

Patient-important outcomes in registered diabetes trials.

JAMA·2008
Same author

Glycemic variation and hypoglycemia in patients with well-controlled type 1 diabetes on a multiple daily insulin injection program with use of glargine and ultralente as basal insulin.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2007
Same author

Waking up from the DREAM of preventing diabetes with drugs.

BMJ (Clinical research ed.)·2007
Same journal

Continuous Glucose Monitoring Metrics and Perinatal Outcomes in Pregnant Women with Type 2 Diabetes.

Diabetes technology & therapeutics·2026
Same journal

Invited Commentary: Using Large Clinical Databases.

Diabetes technology & therapeutics·2026
Same journal

Impact of Technology Introduction on Glycemic Control of People Living with Type 1 Diabetes in Belgium: An Observational, Real-World Study.

Diabetes technology & therapeutics·2026
Same journal

Differences in Achieving Stringent Glycemic Targets Among Youth with Type 1 Diabetes: A SWEET Registry Study.

Diabetes technology & therapeutics·2026
Same journal

<i>Letter:</i> "Nocturnal Hypoglycemia: Characterization with Continuous Glucose Monitoring in a Real-World Setting".

Diabetes technology & therapeutics·2026
Same journal

Transient Benign Ketosis Is Common in Type 1 Diabetes During Very-Low Carbohydrate States: Novel Data from Continuous Ketone Sensor.

Diabetes technology & therapeutics·2026
See all related articles